The time for cost-effectiveness in the new European Union member states

The development and role of health economics and technology assessment in the mirror of the Hungarian experience

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Sophisticated methodology and research centres of health economics and health technology assessment were established in the developed countries over the past 30 years, releasing more and more studies of better and better quality every year. A crucial factor in health policy and reimbursement decisions in these countries is cost-effectiveness results. Due to methodological diversification, results of locally performed health economics studies are constrained in international utility. This fact encourages us to set the current goal of greatest importance, i.e. to standardise country-specific methods, thereby promoting transferability and adaptability of results, being backed by each important health care organisation all over Europe. The situation in the new member states [European Union (EU)12] is profoundly different compared with EU15. In these countries, neither the necessary research institutions nor professionals are in place in sufficient numbers; even in most EU12 countries, the importance of cost-effectiveness has not yet been realised. The present study focuses mainly on the EU12. These countries are absolutely dependent on cost-effectiveness results from abroad, and this seems to persist in the long-term. Transferability and adaptability of the results of health economics studies carried out elsewhere through European collaboration is vital for these countries.

Original languageEnglish
Pages (from-to)83-88
Number of pages6
JournalEuropean Journal of Health Economics
Volume8
Issue number2
DOIs
Publication statusPublished - Jun 2007

Fingerprint

Biomedical Technology Assessment
European Union
Cost-Benefit Analysis
Economics
Health
Health Policy
Research
Developed Countries
Organizations
Delivery of Health Care
Health economics
Technology assessment
Health technology
Cost-effectiveness
Adaptability
Transferability

Keywords

  • Central Europe
  • Health economic evaluation
  • Hungary

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

@article{5152c7cdee46427590bba383bc906776,
title = "The time for cost-effectiveness in the new European Union member states: The development and role of health economics and technology assessment in the mirror of the Hungarian experience",
abstract = "Sophisticated methodology and research centres of health economics and health technology assessment were established in the developed countries over the past 30 years, releasing more and more studies of better and better quality every year. A crucial factor in health policy and reimbursement decisions in these countries is cost-effectiveness results. Due to methodological diversification, results of locally performed health economics studies are constrained in international utility. This fact encourages us to set the current goal of greatest importance, i.e. to standardise country-specific methods, thereby promoting transferability and adaptability of results, being backed by each important health care organisation all over Europe. The situation in the new member states [European Union (EU)12] is profoundly different compared with EU15. In these countries, neither the necessary research institutions nor professionals are in place in sufficient numbers; even in most EU12 countries, the importance of cost-effectiveness has not yet been realised. The present study focuses mainly on the EU12. These countries are absolutely dependent on cost-effectiveness results from abroad, and this seems to persist in the long-term. Transferability and adaptability of the results of health economics studies carried out elsewhere through European collaboration is vital for these countries.",
keywords = "Central Europe, Health economic evaluation, Hungary",
author = "L. Gul{\'a}csi",
year = "2007",
month = "6",
doi = "10.1007/s10198-007-0046-5",
language = "English",
volume = "8",
pages = "83--88",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - The time for cost-effectiveness in the new European Union member states

T2 - The development and role of health economics and technology assessment in the mirror of the Hungarian experience

AU - Gulácsi, L.

PY - 2007/6

Y1 - 2007/6

N2 - Sophisticated methodology and research centres of health economics and health technology assessment were established in the developed countries over the past 30 years, releasing more and more studies of better and better quality every year. A crucial factor in health policy and reimbursement decisions in these countries is cost-effectiveness results. Due to methodological diversification, results of locally performed health economics studies are constrained in international utility. This fact encourages us to set the current goal of greatest importance, i.e. to standardise country-specific methods, thereby promoting transferability and adaptability of results, being backed by each important health care organisation all over Europe. The situation in the new member states [European Union (EU)12] is profoundly different compared with EU15. In these countries, neither the necessary research institutions nor professionals are in place in sufficient numbers; even in most EU12 countries, the importance of cost-effectiveness has not yet been realised. The present study focuses mainly on the EU12. These countries are absolutely dependent on cost-effectiveness results from abroad, and this seems to persist in the long-term. Transferability and adaptability of the results of health economics studies carried out elsewhere through European collaboration is vital for these countries.

AB - Sophisticated methodology and research centres of health economics and health technology assessment were established in the developed countries over the past 30 years, releasing more and more studies of better and better quality every year. A crucial factor in health policy and reimbursement decisions in these countries is cost-effectiveness results. Due to methodological diversification, results of locally performed health economics studies are constrained in international utility. This fact encourages us to set the current goal of greatest importance, i.e. to standardise country-specific methods, thereby promoting transferability and adaptability of results, being backed by each important health care organisation all over Europe. The situation in the new member states [European Union (EU)12] is profoundly different compared with EU15. In these countries, neither the necessary research institutions nor professionals are in place in sufficient numbers; even in most EU12 countries, the importance of cost-effectiveness has not yet been realised. The present study focuses mainly on the EU12. These countries are absolutely dependent on cost-effectiveness results from abroad, and this seems to persist in the long-term. Transferability and adaptability of the results of health economics studies carried out elsewhere through European collaboration is vital for these countries.

KW - Central Europe

KW - Health economic evaluation

KW - Hungary

UR - http://www.scopus.com/inward/record.url?scp=34248331756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248331756&partnerID=8YFLogxK

U2 - 10.1007/s10198-007-0046-5

DO - 10.1007/s10198-007-0046-5

M3 - Article

VL - 8

SP - 83

EP - 88

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - 2

ER -